Pressure on prices of US generics decreases in second quarter, but pharmaceutical companies still require a stronger product selection.
Pharmaceutical companies in India are experiencing a period of double-digit revenue growth, despite ongoing challenges in their largest export market, North America. The September quarter saw companies reporting an average revenue growth of 14-15%, thanks to a stabilization in the US generics market. However, concerns remain about the potential return of pricing pressures that have…